当前位置:首页 - 行情中心 - 福安药业(300194) - 财务分析 - 现金流量表

福安药业

(300194)

  

流通市值:37.67亿  总市值:46.28亿
流通股本:9.68亿   总股本:11.90亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金872,405,707.49444,112,325.521,793,158,987.421,368,435,745.19
  收到的税费返还3,682,714.731,825,015.8710,800,974.854,864,001.42
  收到其他与经营活动有关的现金18,104,211.4810,818,214.3979,188,913.454,992,966.88
  经营活动现金流入小计894,192,633.7456,755,555.781,883,148,875.671,428,292,713.49
  购买商品、接受劳务支付的现金301,755,897.05137,072,749.94696,894,782.44552,437,246.01
  支付给职工以及为职工支付的现金214,043,349.69125,967,597.4408,755,828.62324,352,473.22
  支付的各项税费77,329,588.9841,298,679.4147,381,131.67112,949,935.35
  支付其他与经营活动有关的现金117,084,321.1768,163,202.85317,792,474.22277,517,268.98
  经营活动现金流出小计710,213,156.89372,502,229.591,570,824,216.951,267,256,923.56
  经营活动产生的现金流量净额183,979,476.8184,253,326.19312,324,658.72161,035,789.93
二、投资活动产生的现金流量:
  收回投资收到的现金575,000,000150,000,000140,000,000100,000,000
  取得投资收益收到的现金2,097,499.531,172,389.0323,906,663.0123,545,238.35
  处置固定资产、无形资产和其他长期资产收回的现金净额34,4005,4005,910,8365,482,266
  收到的其他与投资活动有关的现金35,520,049.2635,505,049.2641,174,678.8141,167,878.81
  投资活动现金流入小计612,651,948.79186,682,838.29210,992,177.82170,195,383.16
  购建固定资产、无形资产和其他长期资产支付的现金47,057,730.7833,364,208.05108,432,468.495,421,949.06
  投资支付的现金495,000,000170,000,000260,000,000150,000,000
  支付其他与投资活动有关的现金50,000,00050,000,00065,115,00060,100,000
  投资活动现金流出小计592,057,730.78253,364,208.05433,547,468.4305,521,949.06
  投资活动产生的现金流量净额20,594,218.01-66,681,369.76-222,555,290.58-135,326,565.9
三、筹资活动产生的现金流量:
  取得借款收到的现金58,400,00018,400,0001,051,796,685.93903,596,685.93
  收到其他与筹资活动有关的现金35,476,445.5134,312,334.18109,022,477.75108,859,329.22
  筹资活动现金流入小计93,876,445.5152,712,334.181,160,819,163.681,012,456,015.15
  偿还债务支付的现金248,339,313.05159,139,313.05971,147,928.1713,147,928.1
  分配股利、利润或偿付利息支付的现金67,123,097.543,989,441.49104,990,902.6899,760,132.62
  支付其他与筹资活动有关的现金65,070,571.7459,925,211.4394,636,099.5967,588,613.09
  筹资活动现金流出小计380,532,982.33223,053,965.971,170,774,930.37880,496,673.81
  筹资活动产生的现金流量净额-286,656,536.82-170,341,631.79-9,955,766.69131,959,341.34
四、汇率变动对现金及现金等价物的影响-750,615.19-330,389.62356,594.08488,206.44
五、现金及现金等价物净增加额-82,833,457.19-153,100,064.9880,170,195.53158,156,771.81
  加:期初现金及现金等价物余额828,449,708.94828,449,708.94748,279,513.41748,279,513.41
  期末现金及现金等价物余额745,616,251.75675,349,643.96828,449,708.94906,436,285.22
补充资料:
  净利润95,532,402.66-76,485,660.76-
  资产减值准备5,547,170.47-156,174,215.32-
  固定资产和投资性房地产折旧80,745,144.9-161,476,378.72-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧80,745,144.9-161,476,378.72-
  无形资产摊销18,695,492.86-42,675,768.77-
  长期待摊费用摊销859,142.16-1,258,682.47-
  处置固定资产、无形资产和其他长期资产的损失-10,303.05--266,139.3-
  固定资产报废损失1,641,099.39-2,653,826.57-
  公允价值变动损失-346,712.32-1,861,434.87-
  财务费用8,348,441.09-21,087,406.64-
  投资损失-20,370,234.7--138,550,591.55-
  递延所得税-3,887,203.18--21,973,951.17-
  其中:递延所得税资产减少-2,198,954.3--16,178,834.34-
    递延所得税负债增加-1,688,248.88--5,795,116.83-
  存货的减少-44,708,281.32-215,303,832.38-
  经营性应收项目的减少-3,590,504.43-77,950,023.27-
  经营性应付项目的增加45,033,253.1--285,653,077.06-
  其他--725,316.45-
  现金的期末余额745,616,251.75-828,449,708.94-
  减:现金的期初余额828,449,708.94-748,279,513.41-
  现金及现金等价物的净增加额-82,833,457.19-80,170,195.53-
公告日期2026-08-272026-04-272026-04-272025-10-28
审计意见(境内)标准无保留意见
TOP↑